132 related articles for article (PubMed ID: 3484673)
1. Dihydrofolate-mediated reversal of methotrexate toxicity to hepatoma cells in vitro.
Kruger-McDermott C; Balinska M; Galivan J
Cancer Lett; 1986 Jan; 30(1):79-84. PubMed ID: 3484673
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells.
Boarman DM; Baram J; Allegra CJ
Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989
[TBL] [Abstract][Full Text] [Related]
3. Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
Rhee MS; Coward JK; Galivan J
Mol Pharmacol; 1992 Nov; 42(5):909-16. PubMed ID: 1435754
[TBL] [Abstract][Full Text] [Related]
4. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
5. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.
Galivan J; Nimec Z; Rhee M; Boschelli D; Oronsky AL; Kerwar SS
Cancer Res; 1988 May; 48(9):2421-5. PubMed ID: 2965613
[TBL] [Abstract][Full Text] [Related]
6. Folinic acid protects against suppression of growth by methotrexate in mice.
Iqbal MP; Sultana F; Mehboobali N; Pervez S
Biopharm Drug Dispos; 2001 May; 22(4):169-78. PubMed ID: 11745919
[TBL] [Abstract][Full Text] [Related]
7. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
Balińska M
Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
[TBL] [Abstract][Full Text] [Related]
8. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
Allegra CJ; Boarman D
Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
[TBL] [Abstract][Full Text] [Related]
9. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
10. 5-Methyltetrahydrofolate transport by hepatoma cells and methotrexate-resistant sublines in culture.
Galivan J
Cancer Res; 1981 May; 41(5):1757-62. PubMed ID: 6971149
[TBL] [Abstract][Full Text] [Related]
11. Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (gamma-glutamate) metabolites.
McGuire JJ; Hart BP; Haile WH; Magee KJ; Rhee M; Bolanowska WE; Russell C; Galivan J; Paul B; Coward JK
Biochem Pharmacol; 1996 Oct; 52(8):1295-303. PubMed ID: 8937438
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.
Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
Rosenblatt DS; Whitehead VM; Matiaszuk NV; Pottier A; Vuchich MJ; Beaulieu D
Mol Pharmacol; 1982 May; 21(3):718-22. PubMed ID: 6180291
[TBL] [Abstract][Full Text] [Related]
15. Aspects of the reversal of methotrexate toxicity in rodents.
Kisliuk RL; Tattersall MH; Gaumont Y; Pastore EJ; Brown B
Cancer Treat Rep; 1977 Jul; 61(4):647-50. PubMed ID: 301779
[TBL] [Abstract][Full Text] [Related]
16. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
Galivan J; Nimec Z; Rhee M
Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
[TBL] [Abstract][Full Text] [Related]
17. gamma-Fluoromethotrexate: synthesis and biological activity of a potent inhibitor of dihydrofolate reductase with greatly diminished ability to form poly-gamma-glutamates.
Galivan J; Inglese J; McGuire JJ; Nimec Z; Coward JK
Proc Natl Acad Sci U S A; 1985 May; 82(9):2598-602. PubMed ID: 2581252
[TBL] [Abstract][Full Text] [Related]
18. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
Seither RL; Rape TJ; Goldman ID
Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
Miyachi H; Takemura Y; Kobayashi H; Ando Y
Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
[TBL] [Abstract][Full Text] [Related]
20. Hormonal alteration of methotrexate and folate polyglutamate formation in cultured hepatoma cells.
Galivan J
Arch Biochem Biophys; 1984 Apr; 230(1):355-62. PubMed ID: 6370141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
